Literature DB >> 32602774

Aortic valve: anatomy and structure and the role of vasculature in the degenerative process.

Vasiliki Katsi1, Nikolaos Magkas1, Alexios Antonopoulos1, Georgios Trantalis1, Konstantinos Toutouzas1, Dimitrios Tousoulis1.   

Abstract

Aortic valve stenosis is a degenerative disease affecting increasing number of individuals and characterised by thickening, calcification and fibrosis of the valve resulting in restricted valve motion. Degeneration of the aortic valve is no longer considered a passive deposition of calcium, but an active process that involves certain mechanisms, that is endothelial dysfunction, inflammation, increased oxidative stress, calcification, bone formation, lipid deposition, extracellular matrix (ECM) remodelling and neoangiogenesis. Accumulating evidence indicates an important role for neoangiogenesis (i.e. formation of new vessels) in the pathogenesis of aortic valve stenosis. The normal aortic valve is generally an avascular tissue supplied with oxygen and nutrients via diffusion from the circulating blood. In contrast, presence of intrinsic micro-vasculature has been demonstrated in stenotic and calcified valves. Importantly, presence and density of neovessels have been associated with inflammation, calcification and bone formation. It remains unclear whether neoangiogenesis is a compensatory mechanism aiming to counteract hypoxia and increased metabolic demands of the thickened tissue or represents an active contributor to disease progression. Data extracted mainly from animal studies are supportive of a direct detrimental effect of neoangiogenesis, however, robust evidence from human studies is lacking. Thus, there is inadequate knowledge to assess whether neoangiogenesis could serve as a future therapeutic target for a disease that no effective medical therapy exists. In this review, we present basic aspects of anatomy and structure of the normal and stenotic aortic valve and we focus on the role of valve vasculature in the natural course of valve calcification and stenosis.

Entities:  

Keywords:  Aortic valve; aortic stenosis; calcification; leaflets; neoangiogenesis

Year:  2020        PMID: 32602774     DOI: 10.1080/00015385.2020.1746053

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  7 in total

Review 1.  Low-Gradient Aortic Stenosis; the Diagnostic Dilemma.

Authors:  Osama Alkhalaila; Mansour Al Shehadat
Journal:  Heart Views       Date:  2022-05-16

Review 2.  Mechanisms and Drug Therapies of Bioprosthetic Heart Valve Calcification.

Authors:  Shuyu Wen; Ying Zhou; Wai Yen Yim; Shijie Wang; Li Xu; Jiawei Shi; Weihua Qiao; Nianguo Dong
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

3.  Fibroblast growth factor 2 inhibits myofibroblastic activation of valvular interstitial cells.

Authors:  Marcus Ground; Steve Waqanivavalagi; Young-Eun Park; Karen Callon; Robert Walker; Paget Milsom; Jillian Cornish
Journal:  PLoS One       Date:  2022-06-17       Impact factor: 3.752

4.  Atractylenolide-1 Targets FLT3 to Regulate PI3K/AKT/HIF1-α Pathway to Inhibit Osteogenic Differentiation of Human Valve Interstitial Cells.

Authors:  Jie Wang; Penghua Zhang; Jing Zhang; Zhaohui Ma; Xingqin Tian; Yan Liu; Guanghui Lv; Linghang Qu
Journal:  Front Pharmacol       Date:  2022-04-25       Impact factor: 5.988

Review 5.  Implication of Lipids in Calcified Aortic Valve Pathogenesis: Why Did Statins Fail?

Authors:  Mohamed J Nsaibia; Anichavezhi Devendran; Eshak Goubaa; Jamal Bouitbir; Romain Capoulade; Rihab Bouchareb
Journal:  J Clin Med       Date:  2022-06-10       Impact factor: 4.964

6.  Ultrastructural Pathology of Atherosclerosis, Calcific Aortic Valve Disease, and Bioprosthetic Heart Valve Degeneration: Commonalities and Differences.

Authors:  Alexander Kostyunin; Rinat Mukhamadiyarov; Tatiana Glushkova; Leo Bogdanov; Daria Shishkova; Nikolay Osyaev; Evgeniy Ovcharenko; Anton Kutikhin
Journal:  Int J Mol Sci       Date:  2020-10-09       Impact factor: 5.923

7.  Early Aberrant Angiogenesis Due to Elastic Fiber Fragmentation in Aortic Valve Disease.

Authors:  Robert B Hinton; Amy L Juraszek; Amy M Opoka; Benjamin J Landis; J Michael Smith; Robert P Mecham; Kevin E Bove
Journal:  J Cardiovasc Dev Dis       Date:  2021-06-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.